BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 38574385)

  • 1. Comparison of transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in wild-type and PPARα knockout mouse hepatocytes.
    Heintz MM; Klaren WD; East AW; Haws LC; McGreal SR; Campbell RR; Thompson CM
    Toxicol Sci; 2024 Jun; 200(1):183-198. PubMed ID: 38574385
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparison of transcriptomic profiles between HFPO-DA and prototypical PPARα, PPARγ, and cytotoxic agents in mouse, rat, and pooled human hepatocytes.
    Heintz MM; Klaren WD; East AW; Haws LC; McGreal SR; Campbell RR; Thompson CM
    Toxicol Sci; 2024 Jun; 200(1):165-182. PubMed ID: 38574381
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Assessment of the mode of action underlying development of liver lesions in mice following oral exposure to HFPO-DA and relevance to humans.
    Heintz MM; Haws LC; Klaunig JE; Cullen JM; Thompson CM
    Toxicol Sci; 2023 Mar; 192(1):15-29. PubMed ID: 36629480
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Evaluation of Transcriptomic Responses in Livers of Mice Exposed to the Short-Chain PFAS Compound HFPO-DA.
    Heintz MM; Chappell GA; Thompson CM; Haws LC
    Front Toxicol; 2022; 4():937168. PubMed ID: 35832492
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vitro activity of a panel of per- and polyfluoroalkyl substances (PFAS), fatty acids, and pharmaceuticals in peroxisome proliferator-activated receptor (PPAR) alpha, PPAR gamma, and estrogen receptor assays.
    Evans N; Conley JM; Cardon M; Hartig P; Medlock-Kakaley E; Gray LE
    Toxicol Appl Pharmacol; 2022 Aug; 449():116136. PubMed ID: 35752307
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GenX analogs exposure induced greater hepatotoxicity than GenX mainly via activation of PPARα pathway while caused hepatomegaly in the absence of PPARα in female mice.
    Ren W; Wang Z; Guo H; Gou Y; Dai J; Zhou X; Sheng N
    Environ Pollut; 2024 Mar; 344():123314. PubMed ID: 38218542
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transcriptomic signatures of peroxisome proliferator-activated receptor α (PPARα) in different mouse liver models identify novel aspects of its biology.
    Szalowska E; Tesfay HA; van Hijum SA; Kersten S
    BMC Genomics; 2014 Dec; 15(1):1106. PubMed ID: 25511156
    [TBL] [Abstract][Full Text] [Related]  

  • 8. PPARα-independent transcriptional targets of perfluoroalkyl acids revealed by transcript profiling.
    Rosen MB; Das KP; Rooney J; Abbott B; Lau C; Corton JC
    Toxicology; 2017 Jul; 387():95-107. PubMed ID: 28558994
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Assessment of Mouse Liver Histopathology Following Exposure to HFPO-DA With Emphasis on Understanding Mechanisms of Hepatocellular Death.
    Thompson CM; Heintz MM; Wolf JC; Cheru R; Haws LC; Cullen JM
    Toxicol Pathol; 2023 Jan; 51(1-2):4-14. PubMed ID: 36987989
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peroxisome proliferator-activated receptor (PPAR)-gamma positively controls and PPARalpha negatively controls cyclooxygenase-2 expression in rat brain astrocytes through a convergence on PPARbeta/delta via mutual control of PPAR expression levels.
    Aleshin S; Grabeklis S; Hanck T; Sergeeva M; Reiser G
    Mol Pharmacol; 2009 Aug; 76(2):414-24. PubMed ID: 19483106
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Hexafluoropropylene oxide dimer acid (HFPO-DA) induced developmental cardiotoxicity and hepatotoxicity in hatchling chickens: Roles of peroxisome proliferator activated receptor alpha.
    Xu X; Ni H; Guo Y; Lin Y; Ji J; Jin C; Yuan F; Feng M; Ji N; Zheng Y; Jiang Q
    Environ Pollut; 2021 Dec; 290():118112. PubMed ID: 34500398
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in rat hepatocytes.
    Rogue A; Renaud MP; Claude N; Guillouzo A; Spire C
    Toxicol Appl Pharmacol; 2011 Jul; 254(1):18-31. PubMed ID: 21515302
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Metabolic Profiling of Chicken Embryos Exposed to Perfluorooctanoic Acid (PFOA) and Agonists to Peroxisome Proliferator-Activated Receptors.
    Mattsson A; Kärrman A; Pinto R; Brunström B
    PLoS One; 2015; 10(12):e0143780. PubMed ID: 26624992
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identifying qualitative differences in PPARα signaling networks in human and rat hepatocytes and their significance for next generation chemical risk assessment methods.
    McMullen PD; Bhattacharya S; Woods CG; Pendse SN; McBride MT; Soldatow VY; Deisenroth C; LeCluyse EL; Clewell RA; Andersen ME
    Toxicol In Vitro; 2020 Apr; 64():104463. PubMed ID: 31628012
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differential gene expression in mouse primary hepatocytes exposed to the peroxisome proliferator-activated receptor alpha agonists.
    Guo L; Fang H; Collins J; Fan XH; Dial S; Wong A; Mehta K; Blann E; Shi L; Tong W; Dragan YP
    BMC Bioinformatics; 2006 Sep; 7 Suppl 2(Suppl 2):S18. PubMed ID: 17118139
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparative gene expression profiles induced by PPARγ and PPARα/γ agonists in human hepatocytes.
    Rogue A; Lambert C; Jossé R; Antherieu S; Spire C; Claude N; Guillouzo A
    PLoS One; 2011 Apr; 6(4):e18816. PubMed ID: 21533120
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Perfluorooctanoic acid (PFOA) affects distinct molecular signalling pathways in human primary hepatocytes.
    Buhrke T; Krüger E; Pevny S; Rößler M; Bitter K; Lampen A
    Toxicology; 2015 Jul; 333():53-62. PubMed ID: 25868421
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disruption of peroxisome proliferator-activated receptor α in hepatocytes protects against acetaminophen-induced liver injury by activating the IL-6/STAT3 pathway.
    Zhang Z; Yao T; Zhao N; Liu H; Cheng H; Gonzalez FJ; Wang H; Wang G; Qu A; Wang Y
    Int J Biol Sci; 2022; 18(6):2317-2328. PubMed ID: 35414769
    [No Abstract]   [Full Text] [Related]  

  • 19. Model steatogenic compounds (amiodarone, valproic acid, and tetracycline) alter lipid metabolism by different mechanisms in mouse liver slices.
    Szalowska E; van der Burg B; Man HY; Hendriksen PJ; Peijnenburg AA
    PLoS One; 2014; 9(1):e86795. PubMed ID: 24489787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural Basis for PPARs Activation by The Dual PPARα/γ Agonist Sanguinarine: A Unique Mode of Ligand Recognition.
    Tian S; Wang R; Chen S; He J; Zheng W; Li Y
    Molecules; 2021 Oct; 26(19):. PubMed ID: 34641558
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.